Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-090194

Chief Scientific Officer acquired 4,282 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Barone Francesca · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-25 Grant or award : show line 1 in the form +4,282 $4.67 $19,997 100,809 D
Loading xslF345X05/ownership.xml…